Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/neu transgenic mice.
Int J Oncol
; 34(4): 1139-46, 2009 Apr.
Article
en En
| MEDLINE
| ID: mdl-19287973
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Receptores de Prolactina
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Terapia Combinada
/
Receptor ErbB-2
Límite:
Animals
/
Female
/
Humans
Idioma:
En
Año:
2009
Tipo del documento:
Article